
Headline News: ARK’s Dramatic Portfolio Shake-Up Unveiled
ARK Investment Management continues to capture investors’ attention with its recent portfolio adjustments. In a significant move, ARK sold off 44,152 shares of Ionis Pharmaceuticals through its ARKG ETF, a transaction valued at approximately $1.6 million. This sale forms part of an